Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is designed to compare the safety, tolerability, antiviral activity
and immunological effect of lopinavir/ritonavir plus lamivudine (3TC) versus standard therapy
with 2 nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) plus
lopinavir/ritonavir in the treatment of naïve HIV-1 infected subjects.